Stocks
GlaxoSmithKline (GSK) Cash US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Cash, £ | 4 335 000 000 | 7 877 000 000 | 7 877 000 000 | 5 182 000 000 | 5 182 000 000 | 4 095 000 000 | |||
| Changes by years, y/y, % | 0% | +82% | 0% | -34% | 0% | +5.5% | |||
GlaxoSmithKline. Cash, £
GlaxoSmithKline. Cash, changes, %
GlaxoSmithKline (GSK) Cash US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Cash, £ | 6 504 000 000 | 6 683 000 000 | 5 182 000 000 | 5 182 000 000 | 4 095 000 000 | 4 095 000 000 | ||
| Changes by years, y/y, % | 0% | -7% | -34% | -34% | -41% | |||
| Changes by quarters, q/q, % | 0% | +3% | -22% | 0% | -21% | |||
